Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol

NCT03400800 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1617

Enrollment

INDUSTRY

Sponsor class

Conditions

ASCVD
Risk Factor, Cardiovascular
Elevated Cholesterol

Interventions

DRUG: Inclisiran Sodium
DRUG: Placebo

Sponsor

The Medicines Company